This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
Gainers Athersys, Inc. (NASDAQ: ATHX ) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11, 2022. SKYX Platforms Corp. (NASDAQ: SKYX ) gained 68.6% to settle at $7.03. Benchmark initiated coverage on SKYX Platforms with a Buy rating and announced a price target of $15. ECB Bancorp, Inc. (NASDAQ: ECBK ) jumped 40.9% to close at $14.09. Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS ) climbed 37.1% to close at $1.92. QK International Group Limited (NASDAQ: QK ) gained 32.6% to close at $1.87. JAKKS Pacific, Inc. (NASDAQ: JAKK ) shares surged 31.5% to close at $22.46 after the company reported better-than-expected Q2 results. Better Therapeutics, Inc. (NASDAQ: BTTX ) surged 30.9% to close at $1.99 after the company completed its clinical trial for BT-001, an investigational prescription digital therapeutic that is designed to use nCBT to treat type 2 diabetes. Sunrun Inc. (NASDAQ: RUN ) surged 30% to settle at $30.92 alongside Sunnova Energy International after the company reported strong top-line financial results and reaffirmed guidance.
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
Gainers Athersys, Inc. (NASDAQ: ATHX ) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11, 2022. SKYX Platforms Corp. (NASDAQ: SKYX ) gained 68.6% to settle at $7.03. Benchmark initiated coverage on SKYX Platforms with a Buy rating and announced a price target of $15. ECB Bancorp, Inc. (NASDAQ: ECBK ) jumped 40.9% to close at $14.09. Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS ) climbed 37.1% to close at $1.92. QK International Group Limited (NASDAQ: QK ) gained 32.6% to close at $1.87. JAKKS Pacific, Inc. (NASDAQ: JAKK ) shares surged 31.5% to close at $22.46 after the company reported better-than-expected Q2 results. Better Therapeutics, Inc. (NASDAQ: BTTX ) surged 30.9% to close at $1.99 after the company completed its clinical trial for BT-001, an investigational prescription digital therapeutic that is designed to use nCBT to treat type 2 diabetes. Sunrun Inc. (NASDAQ: RUN ) surged 30% to settle at $30.92 alongside Sunnova Energy International after the company reported strong top-line financial results and reaffirmed guidance.